After years relying on the U.S. government to stockpile and distribute Jynneos, Bavarian Nordic is launching the mpox vaccine into the commercial market. Jynneos, the only FDA-approved mpox vaccine, ...
Aug 22 (Reuters) - Bavarian Nordic (BAVA.CO), opens new tab, subject of a takeover offer valuing the vaccine maker at about 19 billion Danish crowns ($3 billion), reported a higher than expected ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback